Acute and long-term neurologic complications in children with acute lymphoblastic leukemia

Turkish Journal of Pediatrics

Volumn 48, Issue 1, 2006, Pages 1-7

  Aytaç, Selin ^a   Yetgin, Sevgi ^a   Tavil, Betül ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute lymphoblastic leukemia; Children; Neurotoxicity

Indexed keywords

AMINOGLYCOSIDE; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; METHOTREXATE; METHYLPREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTHRALGIA; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CONVULSION; DISEASE FREE INTERVAL; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; DRUG MEGADOSE; DYSARTHRIA; ENCEPHALOMALACIA; FEMALE; HEARING DISORDER; HUMAN; LEUKEMIA RELAPSE; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENTAL DEFICIENCY; NEUROGENIC BLADDER; NEUROLOGICAL COMPLICATION; NEUROPATHY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; RISK ASSESSMENT; SPEECH DISORDER; TEMPOROMANDIBULAR JOINT; TONGUE DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL DISORDER; WALKING DIFFICULTY;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; VINCRISTINE;

EID: 33644799313     PISSN: 00414301     EISSN: 00414301     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Reinders-Messelink HA, Van Weerden TW, Fock JM, Gidding CE, Vingerhoets HM, Schoemaker MM. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukemia. Eur J Ped Neurol 2000; 4: 225-233.
2. Ochs JJ, Bowman WP, Pui CH, Abromowitch M, Mason C, Simone JV. Seizures in childhood lymphoblastic leukemia patients. Lancet 1984; 2: 1422-1424.
3. Ochs JJ. Neurotoxicity due to central nervous system therapy for childhood leukemia. Am J Pediatr Hematol Oncol 1989; 11: 95-105.
4. Maytal J, Grossman R, Yusuf FH, et al. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia. Epilepsia 1995; 36: 831-836.
5. Gay CT, Bodensteiner JB, Nitschke R, Sexauer C, Wilson D. Reversible treatment-related leukoencephalopathy. J Child Neurol 1989; 4: 208-213.
6. Yetgin S, Tuncer AM, Cetin M, et al. Benefit of high dose methylprednisolone in comparison with conventional dose prednisolone during remission-induction therapy in childhood acute lymphoblastic leukemia for long term follow-up. Leukemia 2003; 17: 328-333.
7. Yetgin S, Gurgey A, Tuncer AM, et al. A comparison of the effect of high-dose methylprednisolone with conventional dose prednisolone in acute lymphoblastic leukemia patients with randomization. Leuk Res 1998; 22: 485-493.
8. Ray M, Marwaha RK, Trehan A. Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia. Indian J Pediatr 2002; 69: 185-187.
9. Kellie SJ, Koopmans P, Earl J, et al. Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors. Cancer 2004; 100: 2637-2643.
10. McCarthy GM, Skillings JR. Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer. Oral Surg Oral Med Oral Pathol 1992; 74: 299-304.
11. Sathiapalan RK, El-Solh H. Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature. Pediatr Hematol Oncol 2001; 18: 543-546.
12. Mahoney DH Jr, Shuster JJ, Nitschke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy-a Pediatric Oncology Group Study. J Clin Oncol 1998; 16: 1712-1722.
13. Foreman NK, Mahmoud HH, Rivera GK, Crist WM. Recurrent cerebrovascular accident with L-asparaginase rechallenge. Med Pediatr Oncol 1992; 20: 532-534.
14. Ozon A, Topaloglu H, Cila A, Gunay M, Cetin M. Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemia. Brain Dev 1994; 16: 246-248.
15. Yim YS, Mahoney DH Jr, Oshman DG. Hemiparesis and ischemic changes of the white matter after intrathecal therapy for children with acute lymphocytic leukemia. Cancer 1991, 67: 2058-2061.
16. Waber DP, Silverman LB, Catania L, et al. Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity. J Clin Oncol 2004; 22: 2701-2707.
17. Garwicz S, Aronson S, Elmqvist D, Landberg T. Postirradiation syndrome and EEG findings in children with acute lymphoblastic leukaemia. Acta Paediatr Scand 1975; 64: 399-403.
18. Miyahara M, Azuma E, Hirayama M, et al. Somnolence syndrome in a child following 1200-cGy total body irradiation in an unrelated bone marrow transplantation. Pediatr Hematol Oncol 2000; 17: 489-495.
19. Atra A, Pinkerton CR, Bouffet E, et al. Acute neurotoxicity in children with advanced stage B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukaemia treated with the United Kingdom children cancer study group 9002/9003 protocols. Eur J Cancer 2004; 40: 1346-1350.